Ashiya, Japan

Nobuko Sugimoto

This inventor holds 1 USPTO granted patent. Top assignee: Sawai Pharmaceutical Co., Ltd.. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nobuko Sugimoto. Retrieved from https://idiyas.com/inventor/nobuko-sugimoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nobuko Sugimoto: Innovator in Pharmaceutical Chemistry

Introduction

Nobuko Sugimoto is a prominent inventor based in Ashiya, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative research and development of new compounds.

Latest Patents

Nobuko Sugimoto holds a patent for N-tetrazolyl thiazolecarboxyamide derivatives and their use. This patent includes compounds of the formula: ##STR1## wherein A is a C.sub.1-6 alkyl group, an aryl group which is unsubstituted or substituted with at least one substituent selected from hydroxy, alkoxy, aryl-(C.sub.1-6)alkoxy, C.sub.1-6 alkylcarbonyloxy, halo-(C.sub.1-6)alkyl, halogen, nitro, and amino. She has 1 patent to her name.

Career Highlights

Nobuko Sugimoto is associated with Sawai Pharmaceutical Co., Ltd., where she has been instrumental in advancing pharmaceutical research. Her work has contributed to the development of new therapeutic agents that can potentially improve patient outcomes.

Collaborations

Throughout her career, Nobuko has collaborated with notable colleagues, including Junji Yoshinaga and Takeshi Shoyaki. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Nobuko Sugimoto's contributions to pharmaceutical chemistry exemplify her dedication to innovation and research. Her work continues to influence the field and pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…